⌘K

Login Start Free

Home/Filings/4/0000950170-25-106751

4//SEC Filing

Apuli Maricel 4

Accession 0000950170-25-106751

CIK 0001743881other

View on SEC.gov Company Profile

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 6:29 PM ET

Size

15.3 KB

Accession

0000950170-25-106751

Insider Transaction Report

Form 4

Period: 2025-08-07

BridgeBio Pharma, Inc.BBIO

Chief Accounting Officer

Transactions

Sale
Common Stock
2025-08-07$45.44/sh−1,000$45,440→ 141,859 total

Documents

2 files

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1

filerCIK 0002058197

Filing Metadata

Form type: 4
Filed: Aug 10, 8:00 PM ET
Accepted: Aug 11, 6:29 PM ET
Size: 15.3 KB

View on SEC.gov